Statewide test of a new postmarketing drug surveillance system.
作者信息
Fisher S, Bryant S G, Solovitz B L, Kluge R M
出版信息
Tex Med. 1987 Aug;83(8):59-62.
PMID:3660262
Abstract
摘要
相似文献
1
Statewide test of a new postmarketing drug surveillance system.一种新的上市后药品监测系统的全州范围测试。
Tex Med. 1987 Aug;83(8):59-62.
2
Critical reflection on the collection and evaluation of adverse drug reaction data.对药物不良反应数据收集与评估的批判性思考。
Int J Clin Pharmacol Ther Toxicol. 1985 Apr;23 Suppl 1:S48-53.
3
[Is imputation in drug surveillance reliable?].[药物监测中的插补是否可靠？]
Therapie. 1984 May-Jun;39(3):291-6.
4
Adverse drug reactions.
Hum Toxicol. 1986 May;5(3):161-2.
5
[Necessity and difficulties of quantitative drug monitoring].
Therapie. 1983 May-Jun;38(3):319-23.
6
[Drug by drug imputation of adverse effects in drug monitoring. Attempted comparison of different methods].[药物监测中药物不良反应的逐药归因。不同方法的比较尝试]
Therapie. 1983 May-Jun;38(3):295-302.
7
8
[Drug monitoring].[药物监测]
Bull Soc Ophtalmol Fr. 1985 Nov;Spec No:11-30.
9
The diagnosis of adverse medical events associated with drug treatment.
Adverse Drug React Acute Poisoning Rev. 1987 Spring;6(1):1-35.
10
Revised ADR report permits internal review of drug experience.
Pharm Times. 1986 Dec;52(12):48-50.
Zotero 插件